Read the press coverage around CellPort and stay up-to-date on announcements via our press releases.
The FDA is prioritizing faster reviews for cell and gene therapies, emphasizing early manufacturing focus, domestic production, AI, quality systems, and regulatory clarity.
Read MoreThe FDA is prioritizing faster reviews for cell and gene therapies, emphasizing early manufacturing focus, domestic production, AI, quality systems, and regulatory clarity.
...Read more
ISO/IEC 27001:2022 is the latest global standard for information security management. This certification confirms that CellPort’s security framework—including policies, controls, and procedures—meets rigorous, internationally recognized standards designed to address today’s evolving threats.
...Read more
CellPort’s novel cell management software will be integrated into AsedaSciences’ 3RnD® platform, enhancing data traceability for cell-based New Approach Methods.
...Read more
CellPort takes threats to the availability, integrity, and confidentiality of our clients' information seriously. As such, CellPort is an ISO/IEC 27001:2013 certified provider whose Information Security Management System (ISMS) has received third-party accreditation from the International Standards Organization.
...Read more
CellPort announced the release of their latest cloud-based, Software-as-a-Service (SaaS) product – CellPort Version 2.5, with an extensive list of new features and digital capabilities that streamline cell culture, cell banking, and cell manufacturing for R&D, biotechnology, biopharmaceutical, and contract laboratory organizations.
...Read more
CellPort, a leading provider of laboratory management software specially designed for working with cells, was credited as a contributor in a recent press release from Clayton Pharmaceuticals and VistaPharm (a Vertice company) regarding the FDA approval of Sucralfate Oral Suspension.
...Read more.webp)
On a mission to transform the operational efficiency, accuracy, and reliability of working with cells, CellPort announced the release of version 3.0 of its award-winning Software-as-a-Service (SaaS) product.
...Read more
CellPort, formerly part of Absorption, a Pharmaron company, announced the launch of their latest cloud-based. Software-as-a-Service (SaaS) product – CellPort Cell Culture Suite, the “all-in-one” laboratory software focused on cell culture and cell banking.
...Read more
Montgomery County Community College (MCCC) announced that beginning this semester, all students and teachers within their Biotechnology degree program have full access to CellPort, a leading provider of laboratory management software specially designed for working with cells.
...Read more